Skip to content
10-K

Annual Report

CALLISTO PHARMACEUTICALS INC

0001104659-12-022639

← back to feed
Filed
Mar 30, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 29, 2012 158.52M sh
Shares Diluted FY 2011 · Dec 31, 2011 158.3M sh
Shares Diluted FY 2011 · Dec 31, 2010 69.03M sh
Shares Diluted FY 2011 · Dec 31, 2009 51.39M sh
Capex FY 2011 · Dec 31, 2011 $117.23K
Cash And Equivalents FY 2011 · Dec 31, 2011 $13.24M
Cash And Equivalents FY 2011 · Dec 31, 2010 $1.71M
Cash And Equivalents FY 2011 · Dec 31, 2009 $7.21M
Cash And Equivalents FY 2011 · Dec 31, 2008 $301.32K
Stockholders Equity FY 2011 · Dec 31, 2011 $26.18M
Stockholders Equity FY 2011 · Dec 31, 2010 $3.94M
Current Liabilities FY 2011 · Dec 31, 2011 $4.66M
Current Liabilities FY 2011 · Dec 31, 2010 $7.07M
Total Liabilities FY 2011 · Dec 31, 2011 $7.99M
Total Liabilities FY 2011 · Dec 31, 2010 $10.55M
Current Assets FY 2011 · Dec 31, 2011 $14.42M
Current Assets FY 2011 · Dec 31, 2010 $3.26M
Total Assets FY 2011 · Dec 31, 2011 $14.51M
Total Assets FY 2011 · Dec 31, 2010 $3.36M
Sga Expense FY 2011 · Dec 31, 2011 $7.61M
Sga Expense FY 2011 · Dec 31, 2011 $60.37M
Sga Expense FY 2011 · Dec 31, 2010 $7.34M
Sga Expense FY 2011 · Dec 31, 2009 $5.11M
Net Income FY 2011 · Dec 31, 2011 −$6.79M
Net Income FY 2011 · Dec 31, 2011 −$123.26M
Net Income FY 2011 · Dec 31, 2010 −$25.79M
Net Income FY 2011 · Dec 31, 2009 −$18.36M
Operating Income FY 2011 · Dec 31, 2011 −$20.93M
Operating Income FY 2011 · Dec 31, 2011 −$125.28M
Operating Income FY 2011 · Dec 31, 2010 −$16.93M
Operating Income FY 2011 · Dec 31, 2009 −$8.53M